# Morgan Creek Capital Management, LLC

> Institutional holdings reported to the SEC as of Q2 2026 on Form 13F. CIK 1623781. Source: https://holderbook.com/funds/1623781-morgan-creek-capital-management-llc/

- Reported value: $148.4M
- Positions: 15
- Weight of the ten largest: 99.3%
- Filed: 2026-08-14

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| FIGURE TECHNOLOGY SOLUTIO | [FIGR](https://holderbook.com/stocks/FIGR/) | $136.4M | 4,442,317 | 91.9% | 3 |
| UBER TECHNOLOGIES INC | [UBER](https://holderbook.com/stocks/UBER/) | $3.2M | 45,023 | 2.2% | 3 |
| GEMINI SPACE STA INC | [GEMI](https://holderbook.com/stocks/GEMI/) | $2.4M | 562,229 | 1.6% | 3 |
| LYFT INC | [LYFT](https://holderbook.com/stocks/LYFT/) | $1.4M | 97,716 | 1.0% | 3 |
| FULL TRUCK ALLIANCE CO LTD | [YMM](https://holderbook.com/stocks/YMM/) | $1.4M | 174,105 | 1.0% | 3 |
| IHS HOLDING LIMITED | [IHS](https://holderbook.com/stocks/IHS/) | $1.3M | 154,963 | 0.9% | 3 |
| PLAINS ALL AMERN PIPELINE L | [PAA](https://holderbook.com/stocks/PAA/) | $392.7K | 17,642 | 0.3% | 3 |
| BIOHAVEN LTD | [BHVN](https://holderbook.com/stocks/BHVN/) | $270.7K | 18,193 | 0.2% | 1 |
| ACADIA PHARMACEUTICALS INC | [ACAD](https://holderbook.com/stocks/ACAD/) | $237.7K | 9,395 | 0.2% | 1 |
| VERADERMICS INC | [MANE](https://holderbook.com/stocks/MANE/) | $236.7K | 1,925 | 0.2% | 1 |
| ARRIVENT BIOPHARMA INC | [AVBP](https://holderbook.com/stocks/AVBP/) | $229.3K | 6,600 | 0.2% | 1 |
| PTC THERAPEUTICS INC | [PTCT](https://holderbook.com/stocks/PTCT/) | $224.5K | 2,752 | 0.2% | 1 |
| TAIWAN SEMICONDUCTOR MANUFAC | [TSM](https://holderbook.com/stocks/TSM/) | $216.3K | 453 | 0.1% | 1 |
| REGENERON PHARMACEUTICALS | [REGN](https://holderbook.com/stocks/REGN/) | $207.0K | 332 | 0.1% | 1 |
| INSMED INC | [INSM](https://holderbook.com/stocks/INSM/) | $205.7K | 1,929 | 0.1% | 2 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2026 | -8.5% | +14.8% | -23.3% | 100% |
| Q1 2026 | -19.6% | -4.6% | -15.0% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2026 | $148.4M | 15 |
| Q1 2026 | $151.4M | 9 |
| Q4 2025 | $365.8M | 14 |